Proteasome Inhibition Is Partially Effective in Attenuating Pre-Existing Immunity against Recombinant Adeno-Associated Viral Vectors
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proteasome Inhibition Is Partially Effective in Attenuating Pre-Existing Immunity against Recombinant Adeno-Associated Viral Vectors
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 4, Pages e34684
Publisher
Public Library of Science (PLoS)
Online
2012-04-14
DOI
10.1371/journal.pone.0034684
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine
- (2011) J H McIntosh et al. GENE THERAPY
- Mycophenolate Mofetil Impairs Transduction of Single-Stranded Adeno-Associated Viral Vectors
- (2011) Paula S. Montenegro-Miranda et al. HUMAN GENE THERAPY
- Multiple myeloma: 2011 update on diagnosis, risk-stratification, and management
- (2010) S. Vincent Rajkumar AMERICAN JOURNAL OF HEMATOLOGY
- Mechanisms that determine plasma cell lifespan and the duration of humoral immunity
- (2010) Ian J. Amanna et al. IMMUNOLOGICAL REVIEWS
- Proteasome Inhibitors Enhance Gene Delivery by AAV Virus Vectors Expressing Large Genomes in Hemophilia Mouse and Dog Models: A Strategy for Broad Clinical Application
- (2010) Paul E Monahan et al. MOLECULAR THERAPY
- Preclinical Safety Evaluation of AAV2-sFLT01— A Gene Therapy for Age-related Macular Degeneration
- (2010) Timothy K MacLachlan et al. MOLECULAR THERAPY
- Structure, Assembly and Homeostatic Regulation of the 26S Proteasome
- (2010) Y. Xie Journal of Molecular Cell Biology
- Bortezomib
- (2009) Monique P. Curran et al. DRUGS
- Proteasome Inhibitors Decrease AAV2 Capsid derived Peptide Epitope Presentation on MHC Class I Following Transduction
- (2009) Jonathan D Finn et al. MOLECULAR THERAPY
- Phase I and Pharmacokinetic Study of Bortezomib in Combination with Idarubicin and Cytarabine in Patients with Acute Myelogenous Leukemia
- (2008) E. C. Attar et al. CLINICAL CANCER RESEARCH
- Enhancing transduction of the liver by adeno-associated viral vectors
- (2008) A C Nathwani et al. GENE THERAPY
- Caspase-2 functions upstream of mitochondria in endoplasmic reticulum stress-induced apoptosis by bortezomib in human myeloma cells
- (2008) H. Gu et al. MOLECULAR CANCER THERAPEUTICS
- The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
- (2008) Kirsten Neubert et al. NATURE MEDICINE
- Effect of Gene Therapy on Visual Function in Leber's Congenital Amaurosis
- (2008) James W.B. Bainbridge et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
- Prolonged Susceptibility to Antibody-mediated Neutralization for Adeno-associated Vectors Targeted to the Liver
- (2007) Samuel L Murphy et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started